This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cigna (CI) to Post Q4 Earnings: Here's What You Should Know
by Zacks Equity Research
Cigna's (CI) fourth-quarter results are likely to reflect increased Evernorth and Cigna Healthcare profits.
Should Value Investors Buy Cigna (CI) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $313.59, moving +1.49% from the previous trading session.
Cigna (CI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $308.17, marking a -0.06% move from the previous day.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $315 in the latest trading session, marking a +0.25% move from the prior day.
Investors Heavily Search Cigna Corporation (CI): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Cigna (CI). This makes it worthwhile to examine what the stock has in store.
Top Stock Reports for Bristol-Myers Squibb, Honeywell International & Sony
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Bristol-Myers Squibb Company (BMY), Honeywell International Inc. (HON) and Sony Group Corporation (SONY).
Cigna (CI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $309.23, marking a +1.79% move from the previous day.
Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for CLRG
Cigna (CI) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $304.19, moving -1.97% from the previous trading session.
Here's Why You Should Hold Cigna (CI) Stock in Your Portfolio
by Zacks Equity Research
Cigna (CI) remains well-poised for growth on the back of the solid Evernorth and Cigna Healthcare businesses, an expanding customer base and robust cash-generating abilities.
Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for CLRG
Should Invesco S&P 500 GARP ETF (SPGP) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPGP
Cigna (CI) Stock Moves -0.67%: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $331.85, marking a -0.67% move from the previous day.
Cigna (CI) Stock Moves -0.06%: What You Should Know
by Zacks Equity Research
Cigna (CI) closed the most recent trading day at $334.10, moving -0.06% from the previous trading session.
Zacks Industry Outlook Highlights UnitedHealth Group, Cignat, Humana and Centene
by Zacks Equity Research
UnitedHealth Group, Cignat, Humana and Centene are part of the Zacks Industry Outlook article.
4 HMO Stocks in Focus Despite Tech Costs, Nursing Shortage
by Debasmita Chatterjee
A well-performing government business might aid the Medical-HMO industry. However, expenses incurred for technology advancements and a shortage of nurses will dampen margins. Stocks like UNH, CI, HUM and CNC are likely to ride out the industry storms.
Cigna (CI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $333.16, marking a +1.1% move from the previous day.
Cigna (CI) Stock Moves -0.97%: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $331.45, marking a -0.97% move from the previous day.
Cigna (CI) Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Cigna's (CI) stock price is increasing on the back of solid performances in the Evernorth and Cigna Healthcare businesses.
Cigna (CI) Stock Moves -0.41%: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $332.12, marking a -0.41% move from the previous day.
Cigna (CI) Focuses on Enhancing Pharmacy Offerings in 2023
by Zacks Equity Research
Cigna (CI) decides to integrate cost-effective biosimilars within its commercial formularies from next year in a bid to drive pharmacy revenues.
The Zacks Analyst Blog Highlights UnitedHealth Group, Blackstone, Cigna, Canadian National Railway and PG&E
by Zacks Equity Research
UnitedHealth Group, Blackstone, Cigna, Canadian National Railway and PG&E are included in this Analyst Blog.
Top Analyst Reports for UnitedHealth, Blackstone & Cigna
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Blackstone Inc. (BX) and Cigna Corporation (CI).
Molina Healthcare (MOH) Up 11% in 6 Months: More Room to Run?
by Zacks Equity Research
Molina Healthcare (MOH) is well-poised for growth on growing premiums, membership increases in Government business and sufficient cash reserves.